Human Cytomegaloviruses Expressing Yellow Fluorescent Fusion Proteins - Characterization and Use in Antiviral Screening

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Straschewski, Sarah ^a   Warmer, Martin ^c   Frascaroli, Giada ^a   Hohenberg, Heinrich ^c   Mertens, Thomas ^a   Winkler, Michael ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; GANCICLOVIR; HYBRID PROTEIN; IE2 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; MATRIX PROTEIN; PHOSPHOPROTEIN; PHOTOPROTEIN; PP150 PROTEIN, CYTOMEGALOVIRUS; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ACTIVE TRANSPORT; ARTICLE; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; CYTOMEGALOVIRUS; DRUG EFFECT; DRUG SCREENING; FIBROBLAST; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; MALE; METABOLISM; PROTEIN TRANSPORT; SPECTROFLUOROMETRY; VIROLOGY; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIVIRAL AGENTS; CELL NUCLEUS; CELLS, CULTURED; CYTOMEGALOVIRUS; DRUG EVALUATION, PRECLINICAL; FIBROBLASTS; GANCICLOVIR; HUMANS; IMMEDIATE-EARLY PROTEINS; LUMINESCENT PROTEINS; MALE; MICROSCOPY, FLUORESCENCE; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, FLUORESCENCE; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 77957292908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009174     Document Type: Article

References (69)

1. Pass RF, (2001) Cytomegalovirus. In: Knipe DM, Howley PM, editors. Fields Virology Philadelphia Lippincott Williams & Wilkins pp. 2675-2705.
2. Riedemann NC, Guo RF, Ward PA, (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524.
3. Wathen MW, Stinski MF, (1982) Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol 41: 462-477.
4. Mocarski ES Jr, Courcelle CT, (2001) Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology Philadelphia Lippincott Williams & Wilkins pp. 2629-2673.
5. Heider JA, Yu Y, Shenk T, Alwine JC, (2002) Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein. J Virol 76: 928-932.
6. Marchini A, Liu H, Zhu H, (2001) Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75: 1870-1878.
7. White EA, Clark CL, Sanchez V, Spector DH, (2004) Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J Virol 78: 1817-1830.
8. Reeves M, Murphy J, Greaves R, Fairley J, Brehm A, et al.(2006) Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J Virol 80: 9998-10009.
9. Schmolke S, Kern HF, Drescher P, Jahn G, Plachter B, (1995) The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol 69: 5959-5968.
10. Chevillotte M, Landwehr S, Linta L, Frascaroli G, Lüske A, et al.(2009) Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol 83: 2480-2490.
11. Sanchez V, Mahr JA, Orazio NI, Spector DH, (2007) Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter. J Virol 81: 11730-11736.
12. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, et al.(2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78: 10960-10966.
13. Yu D, Silva MC, Shenk T, (2003) Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci USA 100: 12396-12401.
14. Dunn W, Chou C, Li H, Hai R, Patterson D, et al.(2003) Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA 100: 14223-14228.
15. Baxter MK, Gibson W, (2001) Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third. J Virol 75: 6865-6873.
16. Jons A, Mettenleiter TC, (1997) Green fluorescent protein expressed by recombinant pseudorabies virus as an in vivo marker for viral replication. J Virol Methods 66: 283-292.
17. Desai P, Person S, (1998) Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J Virol 72: 7563-7568.
18. Elliott G, O'Hare P, (1999) Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J Virol 73: 4110-4119.
19. Kerman IA, Enquist LW, Watson SJ, Yates BJ, (2003) Brainstem substrates of sympatho-motor circuitry identified using trans-synaptic tracing with pseudorabies virus recombinants. J Neurosci 23: 4657-4666.
20. Potel C, Kaelin K, Gautier I, Lebon P, Coppey J, et al.(2002) Incorporation of green fluorescent protein into the essential envelope glycoprotein B of herpes simplex virus type 1. J Virol Methods 105: 13-23.
21. Pyner S, Cleary J, Buchan PM, Coote JH, (2001) Tracing functionally identified neurones in a multisynaptic pathway in the hamster and rat using herpes simplex virus expressing green fluorescent protein. Exp Physiol 86: 695-702.
22. Marschall M, Freitag M, Weiler S, Sorg G, Stamminger Th, (2000) Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother 44: 1588-1597.
23. Murphy EA, Streblow DN, Nelson JA, Stinski MF, (2000) The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol 74: 7108-7118.
24. Goodrum FD, Jordan CT, High K, Shenk T, (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 99: 16255-16260.
25. Sanchez V, Clark CL, Yen JY, Dwarakanath R, Spector DH, (2002) Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication. J Virol 76: 2973-2989.
26. Sampaio KL, Cavignac Y, Stierhof YD, Sinzger C, (2005) Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements. J Virol 79: 2754-2767.
27. Heim R, Prasher DC, Tsien RY, (1994) Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci U S A 91: 12501-12504.
28. Patterson G, Day RN, Piston D, (2001) Fluorescent protein spectra. J Cell Sci 114: 837-838.
29. Wallrabe H, Periasamy A, (2005) Imaging protein molecules using FRET and FLIM microscopy. Curr Opin Biotechnol 16: 19-27.
30. Copeland NG, Jenkins NA, Court DL, (2001) Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769-779.
31. Muyrers JP, Zhang Y, Stewart AF, (2001) Techniques: Recombinogenic engineering-new options for cloning and manipulating DNA. Trends Biochem Sci 26: 325-331.
32. Mocarski ES, Kemble GW, Lyle JM, Greaves RF, (1996) A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci USA 93: 11321-11326.
33. Bresnahan WA, Shenk TE, (2000) UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 97: 14506-14511.
34. Schierling K, Buser C, Mertens T, Winkler M, (2005) Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J Virol 79: 3084-3096.
35. Bevilacqua F, Vis-Poynter N, Worrallo J, Gower D, Collins P, et al.(1995) Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV. J Gen Virol 76 (Pt 8): 1927-1935.
36. Iwata M, Vieira J, Byrne M, Horton H, Torok-Storb B, (1999) Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1. Blood 94: 572-578.
37. Meyer HH, Ripalti A, Landini MP, Radsak K, Kern HF, et al.(1997) Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells. J Gen Virol 78 (Pt 10): 2621-2631.
38. AuCoin DP, Smith GB, Meiering CD, Mocarski ES, (2006) Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol 80: 8199-8210.
39. Schmolke S, Drescher P, Jahn G, Plachter B, (1996) Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport. J Virol 69: 1071-1078.
40. Sanchez V, Greis KD, Sztul E, Britt WJ, (2000) Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J Virol 74: 975-986.
41. Dal PF, Andrei G, Daelemans D, Winkler M, Piette J, et al.(2008) Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus. J Virol Methods 151: 66-73.
42. Michel D, Mertens T, (2006) Antiviral Intervention, Resistance, and Perspectives. In: Reddehase MJ, editors. Cytomegaloviruses Wymondham Caister Academic Press pp. 571-590.
43. Zimmermann A, Wilts H, Lenhardt M, Hahn M, Mertens Th, (2000) Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase. Antivir Res 48: 49-60.
44. Bogner E, Reschke M, Reis B, Reis E, Britt W, et al.(1992) Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus. Arch Virol 126: 67-80.
45. Utz U, Britt W, Vugler L, Mach M, (1989) Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol 63: 1995-2001.
46. Este JA, Telenti A, (2007) HIV entry inhibitors. Lancet 370: 81-88.
47. Bilder GE, Krawiec JA, McVety K, Gazit A, Gilon C, et al.(1991) Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am J Physiol 260: C721-C730.
48. Soroceanu L, Akhavan A, Cobbs CS, (2008) Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455: 391-395.
49. Yura Y, Kusaka J, Kondo Y, Tsujimoto H, Yoshida H, et al.(1995) Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1. Arch Virol 140: 1181-1194.
50. Davies SP, Reddy H, Caivano M, Cohen P, (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
51. Soltoff SP, (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28: 453-458.
52. Muranyi W, Haas J, Wagner M, Krohne G, Koszinowski UH, (2002) Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297: 854-857.
53. Park R, Baines JD, (2006) Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J Virol 80: 494-504.
54. Zaharevitz DW, Gussio R, Leost M, Senderowicz AM, Lahusen T, et al.(1999) Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res 59: 2566-2569.
55. Leost M, Schultz C, Link A, Wu YZ, Biernat J, et al.(2000) Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur J Biochem 267: 5983-5994.
56. Bresnahan WA, Boldogh I, Chi P, Thompson EA, Albrecht T, (1997) Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231: 239-247.
57. Korn K, Krausz E, (2007) Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 11: 503-510.
58. Wagner M, Jonjic S, Koszinowski UH, Messerle M, (1999) Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 73: 7056-7060.
59. Messerle M, Crnkovic I, Hammerschmidt W, Ziegler H, Koszinowski UH, (1997) Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 94: 14759-14763.
60. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
61. Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, et al.(2008) Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89: 359-368.
62. Cherepanov PP, Wackernagel W, (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158: 9-14.
63. Sambrook J, Fritsch E, Maniatis T, (1989) Molecular cloning: A laboratory manual. New York Cold Spring Harbor Laboratory.
64. Winkler M, Rice SA, Stamminger T, (1994) UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol 68: 3943-3954.
65. Plachter B, Britt W, Vornhagen R, Stamminger T, Jahn G, (1993) Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens. Virology 193: 642-652.
66. Britt WJ, Vugler L, (1987) Structural and immunological characterization of the intracellular forms of an abundant 68,000 Mr human cytomegalovirus protein. J Gen Virol 68 (Pt 7): 1897-1907.
67. Plachter B, Wieczorek L, Scholl BC, Ziegelmaier R, Jahn G, (1992) Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. J Clin Microbiol 30: 201-206.
68. Chee M, Rudolph SA, Plachter B, Barrell B, Jahn G, (1989) Identification of the major capsid protein gene of human cytomegalovirus. J Virol 63: 1345-1353.
69. Frommolt P, Thomas RK, (2008) Standardized high-throughput evaluation of cell-based compound screens. BMC Bioinformatics 9: 475.